Silverback Therapeutics - Ownership and Business Overview

Life ScienceCompany

Silverback Therapeutics Ownership

Who owns Silverback Therapeutics?

.

Silverback Therapeutics Business Overview

Where is Silverback Therapeutics headquartered?

Silverback Therapeutics is headquartered in Seattle, Washington.

How many employees does Silverback Therapeutics have?

Silverback Therapeutics has 67 employees.

What sector is Silverback Therapeutics in?

Silverback Therapeutics is a life science company.

When was Silverback Therapeutics founded?

Silverback Therapeutics was founded in 2016.

Life Science M&A Summary in

Join Mergr to view all 0 acquisitions of life science companies in , including .

Silverback Therapeutics

Silverback Therapeutics, Inc.

500 Fairview Avenue North Suite 600,
Seattle, Washington 98109
United States,
(206) 456-2900
www.silverbacktx.com

Silverback Therapeutics is a clinical-stage biopharmaceutical company, develops tissue targeted therapeutics for the treatment of cancer, chronic viral infections, and other serious diseases. The company's lead product candidate is SBT6050, which is in a Phase I/Ib clinical trial, a TLR8 agonist linker-payload conjugated to a HER2-directed monoclonal antibody that targets tumors, such as breast, gastric, and non-small cell lung cancers. It also focuses on developing SBT6290, a product candidate that is in the preclinical stage, which is a TLR8 linker-payload conjugated to a monoclonal antibody that targets Nectin4, which is expressed in bladder, triple-negative breast, head and neck, and non-small cell lung cancers. Silverback Therapeutics was founded in 2016 and is based in Seattle, Washington.


 Subscribe to unlock this and 208,848
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 201K M&A Transactions
  • 204K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.